Matt Aaron Cavender MD MPH
Interventional Cardiology, Peripheral Endovascular Interventional Cardiology
Physician
Join to View Full Profile
300 Meadowmont Village CirChapel Hill, NC 27517
Phone+1 984-974-2900
Fax+1 984-974-2985
Dr. Cavender is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Brigham and Womens HospitalFellowship, Structural and Peripheral Cardiology, 2015 - 2016- Brigham and Women's HospitalFellowship, Interventional Cardiology, 2014 - 2015
- Brigham and Women's HospitalPost-Doctoral Fellowship, 2012 - 2014
Cleveland Clinic FoundationFellowship, Cardiovascular Disease, 2009 - 2012
Duke University HospitalResidency, Internal Medicine, 2006 - 2009
University of Alabama School of MedicineClass of 2006
Certifications & Licensure
NH State Medical License 2015 - Present
NC State Medical License 2006 - 2026
MA State Medical License 2012 - 2021
AL State Medical License 2014 - 2014
OH State Medical License 2009 - 2013
American Board of Internal Medicine Cardiovascular Disease- American Board of Internal Medicine Interventional Cardiology
Clinical Trials
- Promoting Shared Decision Making for Severe Aortic Stenosis Start of enrollment: 2024 Mar 27
Roles: Contact
Publications & Presentations
PubMed
- Discontinuation of SGLT-2i and GLP-1RA among persons with Type 2 diabetes and atherosclerotic cardiovascular disease treated in US cardiology clinics.Adam J Nelson, Lisa A Kaltenbach, Darren K McGuire, Monica Levya, Hussein R Al-Khalidi
American Heart Journal. 2025-04-01 - Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes.Darren K McGuire, Nikolaus Marx, Sharon L Mulvagh, John E Deanfield, Silvio E Inzucchi
The New England Journal of Medicine. 2025-03-29 - The IMproving treatment decisions for Patients with AortiC stenosis Through Shared Decision Making (IMPACT SDM) Study: study protocol for a cluster randomized stepped ...Karen Sepucha, Sammy Elmariah, K D Valentine, Matthew A Cavender, Yuchiao Chang
Trials. 2024-12-18
Press Mentions
Newsworthy from the School of Medicine, Week of March 28 – April 4April 2nd, 2025- HMN 2025: How Clinical Trial Exhibits Oral Semaglutide Vastly Reduces Coronary Heart Assaults, Strokes in Folks with Kind 2 DiabetesApril 1st, 2025
- Oral Semaglutide (GLP-1) May Reduce Heart Attack, Stroke Risk in Diabetes PatientsMarch 31st, 2025
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
